Skip to content

Efficacy of the shear wave elastography in the pancreas with liver cirrhosis patients

Efficacy of the shear wave elastography in the pancreas with liver cirrhosis patients - Stiffness of pancreas in liver cirrhosis

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000020074
Enrollment
100
Registered
2015-12-05
Start date
2015-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cirrhosis

Interventions

Shear wave elastography glucagon stimulation test oral glucose tolerance test

Sponsors

Ehime University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with liver cirrhosis or chronic hepatitis who will be performed an examination of angiography.

Exclusion criteria

Exclusion criteria: Laboratory increases in pancreatic enzymes. Morphologic changes in pancreas. Past treatment history related to portal hypertension. Diabetes. Alcohol consumer. Administered beta-blockers. Clinical condition that could have caused portal hypertension. Poor pancreatic study with ultrasound.

Design outcomes

Primary

MeasureTime frame
A correlation of the drainage time from pancreas and the stiffness of the pancreas

Secondary

MeasureTime frame
A correlation of the drainage time from pancreas and the hepatic venous pressure gradient (HVPG); and the endocrine function. A correlation of the stiffness (liver, spleen, pancreas) and the HVPG; and the endocrine function; and the parameter of portal hypertension (splenic volume, ascites, varices).

Countries

Japan

Contacts

Public ContactTaira Kuroda

Ehime University Hospital Gastroenterology and Metabology

taira@m.ehime-u.ac.jp81-89-960-5308

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026